Annual Operating Expenses
$130.26 M
-$42.46 M-24.58%
31 December 2023
Summary:
Rigel Pharmaceuticals annual total operating expenses is currently $130.26 million, with the most recent change of -$42.46 million (-24.58%) on 31 December 2023. During the last 3 years, it has fallen by -$6.44 million (-4.71%). RIGL annual operating expenses is now -24.58% below its all-time high of $172.72 million, reached on 31 December 2022.RIGL Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$33.23 M
-$362.00 K-1.08%
30 September 2024
Summary:
Rigel Pharmaceuticals quarterly total operating expenses is currently $33.23 million, with the most recent change of -$362.00 thousand (-1.08%) on 30 September 2024. Over the past year, it has increased by +$1.89 million (+6.05%). RIGL quarterly operating expenses is now -30.11% below its all-time high of $47.54 million, reached on 31 December 2022.RIGL Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RIGL Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -24.6% | +6.0% |
| 3 y3 years | -4.7% | -19.3% |
| 5 y5 years | +11.4% | +2.0% |
RIGL Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -24.6% | at low | -30.1% | +10.6% |
| 5 y | 5 years | -24.6% | +11.4% | -30.1% | +10.6% |
| alltime | all time | -24.6% | +467.1% | -30.1% | +279.5% |
Rigel Pharmaceuticals Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $33.23 M(-1.1%) |
| June 2024 | - | $33.59 M(-2.6%) |
| Mar 2024 | - | $34.48 M(+14.8%) |
| Dec 2023 | $130.26 M(-24.6%) | $30.04 M(-4.1%) |
| Sept 2023 | - | $31.33 M(+0.8%) |
| June 2023 | - | $31.08 M(-17.8%) |
| Mar 2023 | - | $37.82 M(-20.4%) |
| Dec 2022 | $172.72 M(+9.9%) | $47.54 M(+17.2%) |
| Sept 2022 | - | $40.56 M(-2.8%) |
| June 2022 | - | $41.75 M(-2.6%) |
| Mar 2022 | - | $42.88 M(+13.4%) |
| Dec 2021 | $157.13 M(+14.9%) | $37.82 M(-8.2%) |
| Sept 2021 | - | $41.18 M(+5.1%) |
| June 2021 | - | $39.19 M(+0.6%) |
| Mar 2021 | - | $38.95 M(+5.4%) |
| Dec 2020 | $136.70 M(+7.2%) | $36.96 M(+15.4%) |
| Sept 2020 | - | $32.03 M(-3.3%) |
| June 2020 | - | $33.13 M(-4.2%) |
| Mar 2020 | - | $34.58 M(+6.2%) |
| Dec 2019 | $127.47 M(+9.0%) | $32.56 M(-0.1%) |
| Sept 2019 | - | $32.58 M(+3.7%) |
| June 2019 | - | $31.43 M(+1.7%) |
| Mar 2019 | - | $30.89 M(-12.1%) |
| Dec 2018 | $116.91 M(+39.0%) | $35.14 M(+20.5%) |
| Sept 2018 | - | $29.17 M(+4.7%) |
| June 2018 | - | $27.87 M(+12.7%) |
| Mar 2018 | - | $24.73 M(-5.6%) |
| Dec 2017 | $84.10 M(-0.3%) | $26.21 M(+39.8%) |
| Sept 2017 | - | $18.75 M(-3.0%) |
| June 2017 | - | $19.34 M(-2.2%) |
| Mar 2017 | - | $19.79 M(+5.3%) |
| Dec 2016 | $84.35 M(+4.6%) | $18.79 M(-9.4%) |
| Sept 2016 | - | $20.73 M(-6.8%) |
| June 2016 | - | $22.24 M(-1.6%) |
| Mar 2016 | - | $22.60 M(+6.2%) |
| Dec 2015 | $80.64 M(-19.0%) | $21.28 M(+7.6%) |
| Sept 2015 | - | $19.78 M(+3.2%) |
| June 2015 | - | $19.16 M(-6.2%) |
| Mar 2015 | - | $20.42 M(-33.3%) |
| Dec 2014 | $99.50 M(+4.8%) | $30.62 M(+45.5%) |
| Sept 2014 | - | $21.04 M(-17.3%) |
| June 2014 | - | $25.46 M(+13.7%) |
| Mar 2014 | - | $22.39 M(-1.4%) |
| Dec 2013 | $94.94 M(-6.6%) | $22.69 M(+2.0%) |
| Sept 2013 | - | $22.25 M(-8.4%) |
| June 2013 | - | $24.29 M(-5.5%) |
| Mar 2013 | - | $25.71 M(+0.4%) |
| Dec 2012 | $101.63 M | $25.62 M(+0.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2012 | - | $25.57 M(-3.1%) |
| June 2012 | - | $26.38 M(+9.7%) |
| Mar 2012 | - | $24.06 M(-7.1%) |
| Dec 2011 | $91.12 M(+1.6%) | $25.91 M(+15.7%) |
| Sept 2011 | - | $22.40 M(+2.0%) |
| June 2011 | - | $21.95 M(+5.2%) |
| Mar 2011 | - | $20.86 M(+6.1%) |
| Dec 2010 | $89.68 M(-19.7%) | $19.67 M(-10.3%) |
| Sept 2010 | - | $21.92 M(-2.5%) |
| June 2010 | - | $22.48 M(-12.2%) |
| Mar 2010 | - | $25.61 M(-0.9%) |
| Dec 2009 | $111.65 M(-18.3%) | $25.85 M(-3.0%) |
| Sept 2009 | - | $26.66 M(-11.1%) |
| June 2009 | - | $30.00 M(+2.9%) |
| Mar 2009 | - | $29.14 M(-14.3%) |
| Dec 2008 | $136.71 M(+48.4%) | $34.01 M(-12.1%) |
| Sept 2008 | - | $38.68 M(+9.7%) |
| June 2008 | - | $35.28 M(+22.7%) |
| Mar 2008 | - | $28.75 M(+1.7%) |
| Dec 2007 | $92.13 M(+20.4%) | $28.26 M(+38.3%) |
| Sept 2007 | - | $20.43 M(-9.5%) |
| June 2007 | - | $22.56 M(+8.0%) |
| Mar 2007 | - | $20.88 M(+4.3%) |
| Dec 2006 | $76.52 M(+18.7%) | $20.02 M(+6.2%) |
| Sept 2006 | - | $18.85 M(+5.2%) |
| June 2006 | - | $17.93 M(-9.0%) |
| Mar 2006 | - | $19.71 M(+22.4%) |
| Dec 2005 | $64.45 M(+4.6%) | $16.11 M(-5.6%) |
| Sept 2005 | - | $17.06 M(-1.0%) |
| June 2005 | - | $17.24 M(+22.7%) |
| Mar 2005 | - | $14.05 M(-12.2%) |
| Dec 2004 | $61.60 M(+18.7%) | $16.00 M(-5.7%) |
| Sept 2004 | - | $16.98 M(+21.1%) |
| June 2004 | - | $14.01 M(-4.1%) |
| Mar 2004 | - | $14.61 M(+4.5%) |
| Dec 2003 | $51.88 M(-1.7%) | $13.98 M(+6.3%) |
| Sept 2003 | - | $13.15 M(+3.5%) |
| June 2003 | - | $12.71 M(+5.5%) |
| Mar 2003 | - | $12.04 M(+3.0%) |
| Dec 2002 | $52.80 M(+31.1%) | $11.69 M(-15.0%) |
| Sept 2002 | - | $13.75 M(-7.2%) |
| June 2002 | - | $14.83 M(+18.3%) |
| Mar 2002 | - | $12.54 M(+14.1%) |
| Dec 2001 | $40.26 M(-13.0%) | $10.98 M(+3.4%) |
| Sept 2001 | - | $10.62 M(-0.9%) |
| June 2001 | - | $10.72 M(+22.4%) |
| Mar 2001 | - | $8.76 M |
| Dec 2000 | $46.28 M(+101.5%) | - |
| Dec 1999 | $22.97 M | - |
FAQ
- What is Rigel Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for Rigel Pharmaceuticals?
- What is Rigel Pharmaceuticals annual operating expenses year-on-year change?
- What is Rigel Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Rigel Pharmaceuticals?
- What is Rigel Pharmaceuticals quarterly operating expenses year-on-year change?
What is Rigel Pharmaceuticals annual total operating expenses?
The current annual operating expenses of RIGL is $130.26 M
What is the all time high annual operating expenses for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high annual total operating expenses is $172.72 M
What is Rigel Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, RIGL annual total operating expenses has changed by -$42.46 M (-24.58%)
What is Rigel Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of RIGL is $33.23 M
What is the all time high quarterly operating expenses for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high quarterly total operating expenses is $47.54 M
What is Rigel Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, RIGL quarterly total operating expenses has changed by +$1.89 M (+6.05%)